MAP
Madison Avenue Partners Portfolio holdings
AUM
$1.5B
This Quarter Return
+5.09%
1 Year Return
+26.66%
3 Year Return
+137.23%
5 Year Return
+278.64%
10 Year Return
–
AUM
$1.18B
AUM Growth
+$1.18B
(+25%)
Cap. Flow
+$213M
Cap. Flow
% of AUM
18.09%
Top 10 Holdings %
Top 10 Hldgs %
91.35%
Holding
23
New
8
Increased
4
Reduced
5
Closed
1
Top Buys
| 1 |
Markel Group
MKL
|
$171M |
| 2 |
PG&E
PCG
|
$50.7M |
| 3 |
Indivior
INDV
|
$39.3M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$35.6M |
| 5 |
INVX
Innovex International, Inc.
INVX
|
$13.1M |
Top Sells
| 1 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
$75M |
| 2 |
Acadia Healthcare
ACHC
|
$58.1M |
| 3 |
Nelnet
NNI
|
$6.25M |
| 4 |
MAGN
Magnera Corporation
MAGN
|
$1.13M |
| 5 |
Solventum
SOLV
|
$1.11M |
Sector Composition
| 1 | Healthcare | 36.13% |
| 2 | Consumer Staples | 20.01% |
| 3 | Financials | 16.7% |
| 4 | Communication Services | 12.02% |
| 5 | Materials | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Graham Holdings Company
GHC
$4.74B
| $236M | 20.01% | 245,271 +10,000 | +4% | +$9.61M |
|
|
2
Solventum
SOLV
$12.7B
| $214M | 18.16% | 2,813,017 -14,655 | -0.5% | -$1.11M |
|
|
3
Markel Group
MKL
$24.8B
| $171M | 14.5% | +91,357 | New | +$171M |
|
4
John Wiley & Sons Class A
WLY
$2.16B
| $98.4M | 8.35% | 2,208,066 +111,273 | +5% | +$4.96M |
|
5
Theravance Biopharma
TBPH
$699M
| $84.9M | 7.21% | 9,511,150 | – | – |
|
|
6
Indivior
INDV
$3.03B
| $74.3M | 6.3% | 7,792,089 +4,118,663 | +112% | +$39.3M |
|
|
MAGN
7
Magnera Corporation
MAGN
$441M
| $60.7M | 5.16% | 3,344,005 -62,288 | -2% | -$1.13M |
|
|
8
PG&E
PCG
$33.6B
| $50.7M | 4.3% | +2,950,000 | New | +$50.7M |
|
|
INVX
9
Innovex International, Inc.
INVX
$1.19B
| $43.3M | 3.68% | 2,413,608 +727,132 | +43% | +$13.1M |
|
10
Stagwell
STGW
$1.46B
| $43.2M | 3.67% | 7,147,662 | – | – |
|
|
SAGE
11
DELISTED
Sage Therapeutics
SAGE
| $35.6M | 3.02% | +4,477,798 | New | +$35.6M |
|
|
12
Nelnet
NNI
$4.65B
| $25.9M | 2.2% | 233,830 -56,383 | -19% | -$6.25M |
|
13
Columbus McKinnon
CMCO
$430M
| $10.5M | 0.89% | +619,343 | New | +$10.5M |
|
|
SLRN
14
DELISTED
ACELYRIN
SLRN
| $10.2M | 0.87% | +4,142,640 | New | +$10.2M |
|
15
Cannae Holdings
CNNE
$1.09B
| $7.68M | 0.65% | +418,984 | New | +$7.68M |
|
|
FSP
16
Franklin Street Properties
FSP
$172M
| $4.87M | 0.41% | 2,733,418 | – | – |
|
|
TSVT
17
DELISTED
2seventy bio
TSVT
| $2.86M | 0.24% | 579,895 | – | – |
|
18
Pliant Therapeutics
PLRX
$101M
| $2.26M | 0.19% | +1,675,043 | New | +$2.26M |
|
19
Ovid Therapeutics
OVID
$91M
| $769K | 0.07% | 2,465,623 -1,257,004 | -34% | -$392K |
|
20
SharkNinja
SN
$16.5B
| $513K | 0.04% | 6,152 | – | – |
|
|
CRGX
21
DELISTED
CARGO Therapeutics
CRGX
| $411K | 0.03% | +100,952 | New | +$411K |
|
|
22
Acadia Healthcare
ACHC
$2.12B
| $288K | 0.02% | 9,486 -1,915,841 | -100% | -$58.1M |
|
|
EDR
23
DELISTED
Endeavor Group Holdings, Inc.
EDR
| – | – | -2,397,658 | Closed | -$75M |
|